Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peer B Jacobson

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 12, 2015
The Vasopressin 1b Receptor Antagonist A-988315 Blocks Stress Effects on the Retrieval of Object-Recognition MemoryAreg Barsegyan, Piray Atsak, Wilfried B Hornberger, et al.
Endocrine|June 21, 2006
Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese miceEugene N Bush, Robin Shapiro, Michael E Brune, et al.
Marine Drugs|May 7, 2008
Differential effects of domoic acid and E. coli lipopolysaccharide on tumor necrosis factor-alpha, transforming growth factor-beta1 and matrix metalloproteinase-9 release by rat neonatal microglia: evaluation of the direct activation hypothesisAlejandro M S Mayer, Marcio Guzman, Renee Peksa, et al.
Neurobiology of Disease|June 27, 2020
Delayed administration of the human anti-RGMa monoclonal antibody elezanumab promotes functional recovery including spontaneous voiding after spinal cord injury in ratsAndrea J Mothe, Marlon Coelho, Lili Huang, et al.
Neurobiology of Disease|July 10, 2022
Delayed administration of elezanumab, a human anti-RGMa neutralizing monoclonal antibody, promotes recovery following cervical spinal cord injuryAndrea J Mothe, Peer B Jacobson, Mitchell Caprelli, et al.
Metabolism: Clinical and Experimental|August 22, 2006
Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose productionDale S Edgerton, Peer B Jacobson, Terry J Opgenorth, et al.
BMC Veterinary Research|October 6, 2012
Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritisSarah Malek, Susannah J Sample, Zeev Schwartz, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2006
Parallel strategies for the preparation and selection of liver-targeted glucocorticoid receptor antagonistsBradley J Backes, Gregory L Hamilton, Phong Nguyen, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Hepatic knockdown of stearoyl-CoA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid compositionHaiyan Xu, Denise Wilcox, Phong Nguyen, et al.
Basic & Clinical Pharmacology & Toxicology|September 28, 2004
In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonistsArthur A Hancock, Marilyn S Diehl, Ramin Faghih, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 12, 2015
The Vasopressin 1b Receptor Antagonist A-988315 Blocks Stress Effects on the Retrieval of Object-Recognition MemoryAreg Barsegyan, Piray Atsak, Wilfried B Hornberger, et al.
Endocrine|June 21, 2006
Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese miceEugene N Bush, Robin Shapiro, Michael E Brune, et al.
Marine Drugs|May 7, 2008
Differential effects of domoic acid and E. coli lipopolysaccharide on tumor necrosis factor-alpha, transforming growth factor-beta1 and matrix metalloproteinase-9 release by rat neonatal microglia: evaluation of the direct activation hypothesisAlejandro M S Mayer, Marcio Guzman, Renee Peksa, et al.
Neurobiology of Disease|June 27, 2020
Delayed administration of the human anti-RGMa monoclonal antibody elezanumab promotes functional recovery including spontaneous voiding after spinal cord injury in ratsAndrea J Mothe, Marlon Coelho, Lili Huang, et al.
Neurobiology of Disease|July 10, 2022
Delayed administration of elezanumab, a human anti-RGMa neutralizing monoclonal antibody, promotes recovery following cervical spinal cord injuryAndrea J Mothe, Peer B Jacobson, Mitchell Caprelli, et al.
Metabolism: Clinical and Experimental|August 22, 2006
Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose productionDale S Edgerton, Peer B Jacobson, Terry J Opgenorth, et al.
BMC Veterinary Research|October 6, 2012
Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritisSarah Malek, Susannah J Sample, Zeev Schwartz, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2006
Parallel strategies for the preparation and selection of liver-targeted glucocorticoid receptor antagonistsBradley J Backes, Gregory L Hamilton, Phong Nguyen, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Hepatic knockdown of stearoyl-CoA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid compositionHaiyan Xu, Denise Wilcox, Phong Nguyen, et al.
Basic & Clinical Pharmacology & Toxicology|September 28, 2004
In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonistsArthur A Hancock, Marilyn S Diehl, Ramin Faghih, et al.
Pageof 3